学术探索
学术期刊
新闻热点
数据分析
智能评审

Treatment of hyperlipidemia in renal transplant recipients

被引：41
作者：
Arnadottir, M
Berg, AL
机构：
[1] UNIV LUND HOSP, DEPT NEPHROL, S-22185 LUND, SWEDEN
[2] UNIV LUND HOSP, DEPT CLIN CHEM, S-22185 LUND, SWEDEN
来源：
TRANSPLANTATION | 1997年 / 63卷 / 03期
关键词：
D O I：
10.1097/00007890-199702150-00002
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：339 / 345
页数：7
相关论文
共 87 条
[1]   Very-low-density lipoprotein of uremic patients is a poor substrate for bovine lipoprotein lipase in vitro [J].
Amadottir, M ;
Dallongeville, J ;
Fruchart, JC ;
NilssonEhle, P .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (06) :686-690
[2]  
[Anonymous], 1994, CIRCULATION
[3]   LIPOPROTEIN LEVELS AND POSTHEPARIN LIPASE ACTIVITIES IN KIDNEY-TRANSPLANT RECIPIENTS - CYCLOSPORINE VS NON-CYCLOSPORINE-TREATED PATIENTS [J].
ARNADOTTIR, M ;
THYSELL, H ;
NILSSONEHLE, P .
AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (05) :391-396
[4]   LOW-DOSE SIMVASTATIN IS A WELL-TOLERATED AND EFFICACIOUS CHOLESTEROL-LOWERING AGENT IN CYCLOSPORINE-TREATED KIDNEY-TRANSPLANT RECIPIENTS - DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY IN 40 PATIENTS [J].
ARNADOTTIR, M ;
ERIKSSON, LO ;
GERMERSHAUSEN, JI ;
THYSELL, H .
NEPHRON, 1994, 68 (01) :57-62
[5]   EVIDENCE THAT REDUCED LIPOPROTEIN-LIPASE ACTIVITY IS NOT A PRIMARY PATHOGENETIC FACTOR FOR HYPERTRIGLYCERIDEMIA IN RENAL-FAILURE [J].
ARNADOTTIR, M ;
THYSELL, H ;
DALLONGEVILLE, J ;
FRUCHART, JC ;
NILSSONEHLE, P .
KIDNEY INTERNATIONAL, 1995, 48 (03) :779-784
[6]   PLASMA-CONCENTRATION PROFILES OF SIMVASTATIN 3-HYDROXY-3-METHYL-GLUTARYL-COENZYME-A REDUCTASE INHIBITORY ACTIVITY IN KIDNEY-TRANSPLANT RECIPIENTS WITH AND WITHOUT CYCLOSPORINE [J].
ARNADOTTIR, M ;
ERIKSSON, LO ;
THYSELL, H ;
KARKAS, JD .
NEPHRON, 1993, 65 (03) :410-413
[7]   Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients [J].
Arnadottir, M ;
Hultberg, B ;
Vladov, V ;
NilssonEhle, P ;
Thysell, H .
TRANSPLANTATION, 1996, 61 (03) :509-512
[8]  
Attman PO, 1996, NEPHROL DIAL TRANSPL, V11, P63
[9]  
*BEH AV HYP, 1995, INFORMATION LAKEMEDE, V6, P178
[10]   FUNCTIONAL IMPROVEMENT PRECEDES STRUCTURAL REGRESSION OF ATHEROSCLEROSIS [J].
BENZULY, KH ;
PADGETT, RC ;
KAUL, S ;
PIEGORS, DJ ;
ARMSTRONG, ML ;
HEISTAD, DD .
CIRCULATION, 1994, 89 (04) :1810-1818
123456789